Needle-Free Devices: Technologies and Global Markets
REPORT SCOPE:
This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.
Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).
Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery and Pediatric drug delivery.
The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.
This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.
Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.
Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).
Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery and Pediatric drug delivery.
The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.
This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.
Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
- 36 data tables and 34 additional tables
- Detailed overview of the global markets for needle-free devices and technologies within the industry
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East and Africa
- Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
- Insight into various needle-free technologies that are used in drug delivery and their various application areas
- A look at the government regulations that can affect the global needle-free devices market
- Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
- Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.
CHAPTER 1 INTRODUCTION
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUG DELIVERY DEVICES STRUCTURE OF HUMAN SKIN
Epidermis
Dermis
Hypodermis
Overview of Drug Delivery Systems and Technologies
Needle-free Devices
Drug Delivery, by Technology
Sustained Release Drug Delivery
Prodrug
Implants and Intrauterine Devices
Targeted Drug Delivery
Polymeric Drug Delivery
Drug Delivery Systems, by Route of Administration
Oral Drug Delivery
Injectable or Parental Drug Delivery
Pulmonary Drug Delivery
Nasal Drug Delivery
Oral Mucosal Drug Delivery
Rectal Drug Delivery
Ocular Drug Delivery
Transdermal Drug Delivery
Need for Better Methods of Drug Delivery
Areas of Ongoing Research
CHAPTER 4 NEEDLE-FREE TECHNOLOGY AND DRUG DELIVERY DEVICES
Needle-free Drug Delivery Devices and Types
History of Needle-free Devices
Demand for Needle-free Devices
Advantages of Needle-free Technology
CHAPTER 5 NEEDLE-FREE DEVICE MARKET DYNAMICS
Market Drivers
Increasing Incidence of Needlestick Injuries
Growing Cases of Needle Phobia
Increasing Demand for Painless Drug Delivery
Product Innovations
Increased Prevalence of Diabetes Globally
Increasing Incidence of Blood-Borne Diseases Globally
Growing Cases of HIV/AIDS
Market Restraints
Comparative High Cost of Needle-free Technology
Alternatives Available for Drug Delivery
High R&D Investments
Market Competition
Short Product Life Cycle
Competitive Landscape
CHAPTER 6 MARKET BREAKDOWN BY PRODUCT TYPE
Introduction
Needle-free Injectors
Introduction
Historical Background
Clinical Need
Components
Mechanism of Action
Applications
Unmet Needs
Future Developments
Needle-free Injectors Market, by Region
Needle-free Injectors Types
Needle-free Injectors, by Medication
Needle-free Injectors, by Drug Delivery
Needle-free Injectors, by Source of Power
Needle-free Injectors, by Usage Type
Inhaler Technologies
Pulmonary Drug Delivery
Advantages and Disadvantages of Inhaler Technologies
Advances in Pulmonary Drug Delivery
Future Developments
Inhaler Technologies Market, by Region
Type of Inhalers
Metered Dose Inhalers
Dry Powder Inhalers
Transdermal Patch Technologies
Transdermal Drug Delivery
Clinical Need
Historical Background
Types of Transdermal Patches
Components
Benefits of Transdermal Patches Over Other Dosage Forms
New Innovations in Transdermal Patches
Clinical Issues of Transdermal Delivery
Future Developments
Transdermal Patch Technologies Market, by Region
Other Novel Technologies
Microneedles
Pen Needles
CHAPTER 7 MARKET BREAKDOWN BY APPLICATION
Application of Needle-free Devices
Pain Management
Vaccine Delivery
Insulin Delivery
Pediatric Drug Delivery
CHAPTER 8 MARKET BREAKDOWN BY REGION
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
South America
Middle East and Africa
CHAPTER 9 MARKET STRATEGY
Market Strategy
Key Mergers and Acquisitions
Exclusive Partnership Announced by PharmaJet and Mundipharma
Aequus and Corium Jointly Collaborate for Transdermal Patches
United Therapeutics Corp. Entered into Licensing Agreement
Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
Medherant Signed an Agreement with a Japanese Company
3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
Cipla and MannKind Corp. Entered into Collaboration
Increasing Adoption of Home Healthcare Concept
Key Product and Technology Developments
Hind Syringes Developed Disposable Pen Needle
BD Introduced New Pen Needle
Development of Innovative Transdermal Patch Technology
Introduction of Smart Inhalers
Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery
CHAPTER 10 MARKETED AND PIPELINE PRODUCTS
Key Marketed Products
Needle-free Injectors
Inhalers
Transdermal Patch
Other Novel Needle Technologies
Pipeline Products
Needle-free Injectors
Metered Dose Inhalers
Transdermal Patches
CHAPTER 11 REGULATORY STRUCTURE
Regional Regulatory Structures
United States
European Union
Japan
China
Hong Kong
Korea
Taiwan
India
FDA Technical Considerations
FDA Recall and Safety Alerts
Occupational Health and Safety Laws
CHAPTER 12 REIMBURSEMENT AND PRICING
Regional Reimbursement Structure
United States
Europe
Japan
Rest of Asia-Pacific
Pricing Trends
CHAPTER 13 CONCLUSIONS AND OUTLOOK FOR NEEDLE-FREE DEVICES
Major Market Influencers
Social Factors
Technological Developments
Demographic and Economic Trends
Transformations in the Healthcare Industry
Future Outlook
CHAPTER 14 COMPANY PROFILES
3M
ACTIVA BRAND PRODUCTS, INC.
AKRA DERMOJET
ALKERMES PLC
AMNIO TECHNOLOGY LLC.
ANTARES PHARMA, INC.
ARADIGM CORP.
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BATTELLE
BESPAK EUROPE LTD.
BIOJECT MEDICAL TECHNOLOGIES
BRISTOL-MYERS SQUIBB
CLEARSIDE BIOMEDICAL, INC.
CORIUM INTERNATIONAL, INC.
CROSSJECT
CAPTISOL
D'ANTONIO CONSULTANTS INTERNATIONAL
DUOJECT MEDICAL SYSTEMS, INC.
DURECT CORP.
ECHO THERAPEUTICS
ENDO INTERNATIONAL
FERNDALE PHARMA GROUP, INC.
FERRING PHARMACEUTICALS, INC.
GERRESHEIMER AG
GLAXOSMITHKLINE PLC
GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
HASELMEIER GMBH
INJEX PHARMA AG
JCR PHARMACEUTICALS CO. LTD.
KEYSTONE INDUSTRIES
LINEAGE THERAPEUTICS, INC.
LOHMANN THERAPIE-SYSTEME AG
MEDICAL INTERNATIONAL TECHNOLOGIES
MEDTRONIC
MERCK SERONO S.A.
MINNESOTA RUBBER & PLASTICS
MYLAN, INC.
NANOPASS TECHNOLOGIES LTD.
NATIONAL MEDICAL PRODUCTS, INC.
NOVARTIS
NOVEN PHARMACEUTICALS
NOVO NORDISK A/S
NYPRO, INC.
PENJET CORP.
SYNERON MEDICAL LTD.
TEAM CONSULTING LTD.
TEVA PHARMACEUTICALS INDUSTRIES LTD.
THERAJECT, INC.
VALERITAS, INC.
VAXXAS PTY LTD.
YPSOMED AG
ZOGENIX, INC.
CHAPTER 15 APPENDIX: LIST OF ABBREVIATIONS
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 DRUG DELIVERY DEVICES STRUCTURE OF HUMAN SKIN
Epidermis
Dermis
Hypodermis
Overview of Drug Delivery Systems and Technologies
Needle-free Devices
Drug Delivery, by Technology
Sustained Release Drug Delivery
Prodrug
Implants and Intrauterine Devices
Targeted Drug Delivery
Polymeric Drug Delivery
Drug Delivery Systems, by Route of Administration
Oral Drug Delivery
Injectable or Parental Drug Delivery
Pulmonary Drug Delivery
Nasal Drug Delivery
Oral Mucosal Drug Delivery
Rectal Drug Delivery
Ocular Drug Delivery
Transdermal Drug Delivery
Need for Better Methods of Drug Delivery
Areas of Ongoing Research
CHAPTER 4 NEEDLE-FREE TECHNOLOGY AND DRUG DELIVERY DEVICES
Needle-free Drug Delivery Devices and Types
History of Needle-free Devices
Demand for Needle-free Devices
Advantages of Needle-free Technology
CHAPTER 5 NEEDLE-FREE DEVICE MARKET DYNAMICS
Market Drivers
Increasing Incidence of Needlestick Injuries
Growing Cases of Needle Phobia
Increasing Demand for Painless Drug Delivery
Product Innovations
Increased Prevalence of Diabetes Globally
Increasing Incidence of Blood-Borne Diseases Globally
Growing Cases of HIV/AIDS
Market Restraints
Comparative High Cost of Needle-free Technology
Alternatives Available for Drug Delivery
High R&D Investments
Market Competition
Short Product Life Cycle
Competitive Landscape
CHAPTER 6 MARKET BREAKDOWN BY PRODUCT TYPE
Introduction
Needle-free Injectors
Introduction
Historical Background
Clinical Need
Components
Mechanism of Action
Applications
Unmet Needs
Future Developments
Needle-free Injectors Market, by Region
Needle-free Injectors Types
Needle-free Injectors, by Medication
Needle-free Injectors, by Drug Delivery
Needle-free Injectors, by Source of Power
Needle-free Injectors, by Usage Type
Inhaler Technologies
Pulmonary Drug Delivery
Advantages and Disadvantages of Inhaler Technologies
Advances in Pulmonary Drug Delivery
Future Developments
Inhaler Technologies Market, by Region
Type of Inhalers
Metered Dose Inhalers
Dry Powder Inhalers
Transdermal Patch Technologies
Transdermal Drug Delivery
Clinical Need
Historical Background
Types of Transdermal Patches
Components
Benefits of Transdermal Patches Over Other Dosage Forms
New Innovations in Transdermal Patches
Clinical Issues of Transdermal Delivery
Future Developments
Transdermal Patch Technologies Market, by Region
Other Novel Technologies
Microneedles
Pen Needles
CHAPTER 7 MARKET BREAKDOWN BY APPLICATION
Application of Needle-free Devices
Pain Management
Vaccine Delivery
Insulin Delivery
Pediatric Drug Delivery
CHAPTER 8 MARKET BREAKDOWN BY REGION
Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
South America
Middle East and Africa
CHAPTER 9 MARKET STRATEGY
Market Strategy
Key Mergers and Acquisitions
Exclusive Partnership Announced by PharmaJet and Mundipharma
Aequus and Corium Jointly Collaborate for Transdermal Patches
United Therapeutics Corp. Entered into Licensing Agreement
Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
Medherant Signed an Agreement with a Japanese Company
3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
Cipla and MannKind Corp. Entered into Collaboration
Increasing Adoption of Home Healthcare Concept
Key Product and Technology Developments
Hind Syringes Developed Disposable Pen Needle
BD Introduced New Pen Needle
Development of Innovative Transdermal Patch Technology
Introduction of Smart Inhalers
Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery
CHAPTER 10 MARKETED AND PIPELINE PRODUCTS
Key Marketed Products
Needle-free Injectors
Inhalers
Transdermal Patch
Other Novel Needle Technologies
Pipeline Products
Needle-free Injectors
Metered Dose Inhalers
Transdermal Patches
CHAPTER 11 REGULATORY STRUCTURE
Regional Regulatory Structures
United States
European Union
Japan
China
Hong Kong
Korea
Taiwan
India
FDA Technical Considerations
FDA Recall and Safety Alerts
Occupational Health and Safety Laws
CHAPTER 12 REIMBURSEMENT AND PRICING
Regional Reimbursement Structure
United States
Europe
Japan
Rest of Asia-Pacific
Pricing Trends
CHAPTER 13 CONCLUSIONS AND OUTLOOK FOR NEEDLE-FREE DEVICES
Major Market Influencers
Social Factors
Technological Developments
Demographic and Economic Trends
Transformations in the Healthcare Industry
Future Outlook
CHAPTER 14 COMPANY PROFILES
3M
ACTIVA BRAND PRODUCTS, INC.
AKRA DERMOJET
ALKERMES PLC
AMNIO TECHNOLOGY LLC.
ANTARES PHARMA, INC.
ARADIGM CORP.
ASTELLAS PHARMA, INC.
ASTRAZENECA PLC
BATTELLE
BESPAK EUROPE LTD.
BIOJECT MEDICAL TECHNOLOGIES
BRISTOL-MYERS SQUIBB
CLEARSIDE BIOMEDICAL, INC.
CORIUM INTERNATIONAL, INC.
CROSSJECT
CAPTISOL
D'ANTONIO CONSULTANTS INTERNATIONAL
DUOJECT MEDICAL SYSTEMS, INC.
DURECT CORP.
ECHO THERAPEUTICS
ENDO INTERNATIONAL
FERNDALE PHARMA GROUP, INC.
FERRING PHARMACEUTICALS, INC.
GERRESHEIMER AG
GLAXOSMITHKLINE PLC
GLIDE PHARMACEUTICAL TECHNOLOGIES LTD.
HASELMEIER GMBH
INJEX PHARMA AG
JCR PHARMACEUTICALS CO. LTD.
KEYSTONE INDUSTRIES
LINEAGE THERAPEUTICS, INC.
LOHMANN THERAPIE-SYSTEME AG
MEDICAL INTERNATIONAL TECHNOLOGIES
MEDTRONIC
MERCK SERONO S.A.
MINNESOTA RUBBER & PLASTICS
MYLAN, INC.
NANOPASS TECHNOLOGIES LTD.
NATIONAL MEDICAL PRODUCTS, INC.
NOVARTIS
NOVEN PHARMACEUTICALS
NOVO NORDISK A/S
NYPRO, INC.
PENJET CORP.
SYNERON MEDICAL LTD.
TEAM CONSULTING LTD.
TEVA PHARMACEUTICALS INDUSTRIES LTD.
THERAJECT, INC.
VALERITAS, INC.
VAXXAS PTY LTD.
YPSOMED AG
ZOGENIX, INC.
CHAPTER 15 APPENDIX: LIST OF ABBREVIATIONS
LIST OF TABLES
Summary Table: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 1: Prodrugs and their Active Metabolites
Table 2: Advantages and Disadvantages of Oral Drug Delivery
Table 3: Advantages and Disadvantages of Injectable Drug Delivery
Table 4: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 5: Advantages and Disadvantages of Nasal Drug Delivery
Table 6: Advantages and Disadvantages of Oral Mucosal Drug Delivery
Table 7: Advantages and Disadvantages of Rectal Drug Delivery
Table 8: Advantages and Disadvantages of Ocular Drug Delivery
Table 9: Advantages and Disadvantages of Transdermal Drug Delivery
Table 10: Global HIV-Infected People and New Cases, by Region, 2016
Table 11: Global Needle-free Device Market Vendors, by Ranking, 2017
Table 12: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 13: Advantages and Disadvantages of Needle-free Injectors
Table 14: Global Market for Needle-free Injectors, by Region, Through 2023
Table 15: Global Market for Needle-free Injectors, by Medication, Through 2023
Table 16: Global Market for Needle-free Injectors, by Drug Delivery, Through 2023
Table 17: Ideal Characteristics of Therapeutic Aerosols
Table 18: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 19: Advantages and Disadvantages of Inhaler Technologies
Table 20: Asthma Prevalence, by Country, 2016-2018
Table 21: Global Market for Inhaler Technologies, by Region, Through 2023
Table 22: Advantages and Disadvantages of Metered Dose Inhalers
Table 23: Advantages and Disadvantages of Standard Press and Breath MDIs
Table 24: Advantages and Disadvantages of Dry Powder Inhalers
Table 25: Global Market for Inhaler Technologies, by Type, Through 2023
Table 26: Ideal Properties of Transdermal Drug Delivery Systems
Table 27: Parameters Affecting Selection of Drugs in Transdermal Drug Delivery Systems
Table 28: Advantages and Disadvantages of Transdermal Patches
Table 29: Global Market for Transdermal Patch Technologies, by Region, Through 2023
Table 30: Global Market for Other Novel Technologies, by Region, Through 2023
Table 31: Advantages and Disadvantages of Microneedle Technologies
Table 32: Advantages and Disadvantages of Pen Needles
Table 33: Top 10 Countries with High Percentage of Diabetic Population, 2017
Table 34: Comparison Between Painful and Painless Needle-free Insulin Drug Delivery Systems
Table 35: Global Market for Needle-free Devices, by Region, Through 2023
Table 36: United States Market for Needle-free Devices, by Product Segment, Through 2023
Table 37: Canadian Market for Needle-free Devices, by Product Segment, Through 2023
Table 38: Mexican Market for Needle-free Devices, by Product Segment, Through 2023
Table 39: European Market for Needle-free Devices, by Product Segment, Through 2023
Table 40: German Market for Needle-free Devices, by Product Segment, Through 2023
Table 41: U.K. Market for Needle-free Devices, by Product Segment, Through 2023
Table 42: French Market for Needle-free Devices, by Product Segment, Through 2023
Table 43: Italian Market for Needle-free Devices, by Product Segment, Through 2023
Table 44: Spanish Market for Needle-free Devices, by Product Segment, Through 2023
Table 45: Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 46: Chinese Market for Needle-free Devices, by Product Segment, Through 2023
Table 47: Indian Market for Needle-free Devices, by Product Segment, Through 2023
Table 48: Japanese Market for Needle-free Devices, by Product Segment, Through 2023
Table 49: South Korean Market for Needle-free Devices, by Product Segment, Through 2023
Table 50: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 51: South American Market for Needle-free Devices, by Product Segment, Through 2023
Table 52: HIV Acquisition in the Middle East and North Africa, by Mode, 2014
Table 53: Middle Eastern and African Market for Needle-free Devices, by Product Segment, Through 2023
Table 54: Key Metered Dose Inhalers in the Market
Table 55: Transdermal Patches: Key Marketed Products
Table 56: Other Novel Technologies: Marketed Products
Table 57: Key Metered Dose Inhalers: Pipeline Products
Table 58: Transdermal Patches: Pipeline Products
Table 59: Differences in Regulatory Approvals in the United States and Europe
Table 60: 3M: Net Revenue, 2015-2017
Table 61: 3M: Marketed Products, 2017
Table 62: Akra Dermojet Brand Products: Marketed Products, 2017
Table 63: Antares Pharma, Inc.: Marketed Products, 2017
Table 64: Aradigm Corp.: Marketed Products, 2017
Table 65: AstraZeneca Plc: Net Revenue, 2015-2017
Table 66: Medtronic: Net Revenue, 2015-2017
Table 67: Novartis: Net Revenue, 2017
Table 68: Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2017
Table 69: Abbreviations Used in Needle-free Devices and Technologies
Summary Table: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 1: Prodrugs and their Active Metabolites
Table 2: Advantages and Disadvantages of Oral Drug Delivery
Table 3: Advantages and Disadvantages of Injectable Drug Delivery
Table 4: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 5: Advantages and Disadvantages of Nasal Drug Delivery
Table 6: Advantages and Disadvantages of Oral Mucosal Drug Delivery
Table 7: Advantages and Disadvantages of Rectal Drug Delivery
Table 8: Advantages and Disadvantages of Ocular Drug Delivery
Table 9: Advantages and Disadvantages of Transdermal Drug Delivery
Table 10: Global HIV-Infected People and New Cases, by Region, 2016
Table 11: Global Needle-free Device Market Vendors, by Ranking, 2017
Table 12: Global Market for Needle-free Devices, by Product Type, Through 2023
Table 13: Advantages and Disadvantages of Needle-free Injectors
Table 14: Global Market for Needle-free Injectors, by Region, Through 2023
Table 15: Global Market for Needle-free Injectors, by Medication, Through 2023
Table 16: Global Market for Needle-free Injectors, by Drug Delivery, Through 2023
Table 17: Ideal Characteristics of Therapeutic Aerosols
Table 18: Advantages and Disadvantages of Pulmonary Drug Delivery
Table 19: Advantages and Disadvantages of Inhaler Technologies
Table 20: Asthma Prevalence, by Country, 2016-2018
Table 21: Global Market for Inhaler Technologies, by Region, Through 2023
Table 22: Advantages and Disadvantages of Metered Dose Inhalers
Table 23: Advantages and Disadvantages of Standard Press and Breath MDIs
Table 24: Advantages and Disadvantages of Dry Powder Inhalers
Table 25: Global Market for Inhaler Technologies, by Type, Through 2023
Table 26: Ideal Properties of Transdermal Drug Delivery Systems
Table 27: Parameters Affecting Selection of Drugs in Transdermal Drug Delivery Systems
Table 28: Advantages and Disadvantages of Transdermal Patches
Table 29: Global Market for Transdermal Patch Technologies, by Region, Through 2023
Table 30: Global Market for Other Novel Technologies, by Region, Through 2023
Table 31: Advantages and Disadvantages of Microneedle Technologies
Table 32: Advantages and Disadvantages of Pen Needles
Table 33: Top 10 Countries with High Percentage of Diabetic Population, 2017
Table 34: Comparison Between Painful and Painless Needle-free Insulin Drug Delivery Systems
Table 35: Global Market for Needle-free Devices, by Region, Through 2023
Table 36: United States Market for Needle-free Devices, by Product Segment, Through 2023
Table 37: Canadian Market for Needle-free Devices, by Product Segment, Through 2023
Table 38: Mexican Market for Needle-free Devices, by Product Segment, Through 2023
Table 39: European Market for Needle-free Devices, by Product Segment, Through 2023
Table 40: German Market for Needle-free Devices, by Product Segment, Through 2023
Table 41: U.K. Market for Needle-free Devices, by Product Segment, Through 2023
Table 42: French Market for Needle-free Devices, by Product Segment, Through 2023
Table 43: Italian Market for Needle-free Devices, by Product Segment, Through 2023
Table 44: Spanish Market for Needle-free Devices, by Product Segment, Through 2023
Table 45: Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 46: Chinese Market for Needle-free Devices, by Product Segment, Through 2023
Table 47: Indian Market for Needle-free Devices, by Product Segment, Through 2023
Table 48: Japanese Market for Needle-free Devices, by Product Segment, Through 2023
Table 49: South Korean Market for Needle-free Devices, by Product Segment, Through 2023
Table 50: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, Through 2023
Table 51: South American Market for Needle-free Devices, by Product Segment, Through 2023
Table 52: HIV Acquisition in the Middle East and North Africa, by Mode, 2014
Table 53: Middle Eastern and African Market for Needle-free Devices, by Product Segment, Through 2023
Table 54: Key Metered Dose Inhalers in the Market
Table 55: Transdermal Patches: Key Marketed Products
Table 56: Other Novel Technologies: Marketed Products
Table 57: Key Metered Dose Inhalers: Pipeline Products
Table 58: Transdermal Patches: Pipeline Products
Table 59: Differences in Regulatory Approvals in the United States and Europe
Table 60: 3M: Net Revenue, 2015-2017
Table 61: 3M: Marketed Products, 2017
Table 62: Akra Dermojet Brand Products: Marketed Products, 2017
Table 63: Antares Pharma, Inc.: Marketed Products, 2017
Table 64: Aradigm Corp.: Marketed Products, 2017
Table 65: AstraZeneca Plc: Net Revenue, 2015-2017
Table 66: Medtronic: Net Revenue, 2015-2017
Table 67: Novartis: Net Revenue, 2017
Table 68: Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2017
Table 69: Abbreviations Used in Needle-free Devices and Technologies
LIST OF FIGURES
Summary Figure: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 1: Diabetes Prevalence, by Region, 2015
Figure 2: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 3: Global Market for Needle-free Injectors, by Region, 2017-2023
Figure 4: Global Market for Needle-free Injectors, by Medication, 2017-2023
Figure 5: Global Market for Needle-free Injectors, by Drug Delivery, 2017-2023
Figure 6: Global Market for Inhaler Technologies, by Region, 2017-2023
Figure 7: Global Market for Inhaler Technologies, by Type, 2017-2023
Figure 8: Global Market for Transdermal Patch Technologies, by Region, 2017-2023
Figure 9: Global Market for Other Novel Technologies, by Region, 2017-2023
Figure 10: Global Market Share for Needle-free Devices, by Application, 2017
Figure 11: Global Market for Needle-free Devices, by Region, 2017-2023
Figure 12: Prevalence of Diabetes in North America, by Country, 2017
Figure 13: United States Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 14: Canadian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 15: Mexican Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 16: Prevalence of Diabetes in Europe, by Country, 2017
Figure 17: European Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 18: German Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 19: U.K. Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 20: French Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 21: Italian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 22: Spanish Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 23: Prevalence of Diabetes in Asia-Pacific, by Country, 2017
Figure 24: Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 25: Chinese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 26: Indian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 27: Japanese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 28: South Korean Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 29: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 30: South American Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 31: Middle Eastern and African Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 32: Diabetes Prevalence in Africa, 2017
Figure 33: Diabetes Prevalence in Middle East and Pakistan, 2017
Figure 34: Diabetes Prevalence in South and Central America, 2017
Figure 35: Diabetes Prevalence in South-East Asia, 2017
Figure 36: Diabetes Prevalence in North America and Caribbean, 2017
Figure 37: Diabetes Prevalence in Europe, 2017
Figure 38: 3M: Net Revenue, by Healthcare Segment, 2015-2017
Summary Figure: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 1: Diabetes Prevalence, by Region, 2015
Figure 2: Global Market for Needle-free Devices, by Product Type, 2017-2023
Figure 3: Global Market for Needle-free Injectors, by Region, 2017-2023
Figure 4: Global Market for Needle-free Injectors, by Medication, 2017-2023
Figure 5: Global Market for Needle-free Injectors, by Drug Delivery, 2017-2023
Figure 6: Global Market for Inhaler Technologies, by Region, 2017-2023
Figure 7: Global Market for Inhaler Technologies, by Type, 2017-2023
Figure 8: Global Market for Transdermal Patch Technologies, by Region, 2017-2023
Figure 9: Global Market for Other Novel Technologies, by Region, 2017-2023
Figure 10: Global Market Share for Needle-free Devices, by Application, 2017
Figure 11: Global Market for Needle-free Devices, by Region, 2017-2023
Figure 12: Prevalence of Diabetes in North America, by Country, 2017
Figure 13: United States Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 14: Canadian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 15: Mexican Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 16: Prevalence of Diabetes in Europe, by Country, 2017
Figure 17: European Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 18: German Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 19: U.K. Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 20: French Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 21: Italian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 22: Spanish Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 23: Prevalence of Diabetes in Asia-Pacific, by Country, 2017
Figure 24: Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 25: Chinese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 26: Indian Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 27: Japanese Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 28: South Korean Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 29: Rest of Asia-Pacific Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 30: South American Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 31: Middle Eastern and African Market for Needle-free Devices, by Product Segment, 2017-2023
Figure 32: Diabetes Prevalence in Africa, 2017
Figure 33: Diabetes Prevalence in Middle East and Pakistan, 2017
Figure 34: Diabetes Prevalence in South and Central America, 2017
Figure 35: Diabetes Prevalence in South-East Asia, 2017
Figure 36: Diabetes Prevalence in North America and Caribbean, 2017
Figure 37: Diabetes Prevalence in Europe, 2017
Figure 38: 3M: Net Revenue, by Healthcare Segment, 2015-2017
